Fingerprint
Dive into the research topics of 'Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically